期刊文献+

脓毒症相关的凝血障碍 被引量:6

Sepsis-related coagulopathy
原文传递
导出
摘要 弥散性血管内凝血(disseminated intravascular coagulation,DIC)是重症领域具有挑战性的综合征,临床诊断相对困难,不同患者的治疗决策迥异。脓毒症诱导的DIC是炎症与凝血系统互相对话相互作用的复杂病理生理过程,因此治疗较为困难。诊断可依据DIC评分系统,治疗以综合治疗为主,包括抗生素合理使用及病灶清除,以及凝血障碍的纠正,防止病情进展和器官功能衰竭。 Disseminated intravascular coagulation(DIC) remains a challenging syndrome for intensivists, as the markers enabling its identification are lacking, and the treatment is patient dependent. The process underlying DIC is a complex interlinked framework of proteases of both the coagulation and inflammatory cascades, thus explaining the difficulty in DIC management. Identification can be accomplished with scoring systems such as the DIC score, and treatment begins with identification and treatment of the underlying infec- tious cause. Supportive care and correction of coagulopathies should be provided simultaneously to prevent irreversible end-organ injury and DIC progression.
作者 刘春峰 Liu Chunfeng(Department of PICU,Shengjing Hospital of China Medical University,Shenyang 110004,China)
出处 《中国小儿急救医学》 CAS 2018年第7期490-493,共4页 Chinese Pediatric Emergency Medicine
关键词 脓毒症 弥散性血管内凝血 凝血障碍 Sepsis Disseminated intravascular coagulation Coagulopathy
  • 相关文献

参考文献1

二级参考文献40

  • 1田永超,张照健,何英,李静,王东强,李志军.脓毒症大鼠炎症与凝血相关性及药物干预的实验研究[J].中国中西医结合急救杂志,2009,16(6):338-341. 被引量:4
  • 2艾宇航,张丽娜,龚华,徐道妙,赵双平,陈江辉.低分子肝素治疗脓毒症的前瞻性临床研究[J].中国危重病急救医学,2005,17(12):736-739. 被引量:43
  • 3张晓娟,马晓春.重症感染患者早期应用小剂量肝素治疗的临床研究[J].中华外科杂志,2006,44(17):1209-1211. 被引量:11
  • 4赵良,许永华,李文放.小剂量未分馏肝素对严重脓毒症防治作用的临床观察[J].解放军医学杂志,2007,32(11):1120-1121. 被引量:3
  • 5Russell JA. Management of sepsis[J].New England Journal of Medicine,2006,(16):1699-1713.
  • 6Lu X,Zhao L,Xu YH. Low molecular weight heparin prevents CLP-induced acute lung injury in rats by anti-inflammatory coagulation[J].Bosn J Basic Med Sci,2013,(01):50-56.
  • 7Spratte J,Meyer zu Schwabedissen H,Endlich N. Heparin inhibits TNF-α signaling in human endometrial stromal cells by interaction with NF-κB[J].Molecular Human Reproduction,2013,(04):227-236.
  • 8Severin IC,Soares A,Hantson J. Glycosaminoglycan analogs as a novel anti-inflammatory strategy[J].Front Immunol,2012.293.
  • 9Abraham E,Reinhart K,Opal S. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis:a randomized controlled trial[J].JAMA:the Journal of the American Medical Association,2003,(02):238-247.
  • 10Bernard GR,Vincent JL,Laterre PF. Efficacy and safety of recombinant human activated protein C for severe sepsis[J].New England Journal of Medicine,2001,(10):699-709.

共引文献24

同被引文献37

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部